Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$3.37M
51.15K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 51.15K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $3.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009521
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
51.15K
Shares to sell
$3.37M
Approx. market value
50.51K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
9/15/2026
20KRestricted Stock Units
N/A
5/9/2020
30.51KTotal acquired50.51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 20K | — |
5/9/2020 | Restricted Stock Units N/A | 30.51K | — |
| Total | 50.51K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
642.00
Market value
$42.6K
9/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50.51K
Market value
$3.32M
9/15/2026
Total
Units
51.15K
Value
$3.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/2/2026 | 642.00 | $42.6K | — | Completed |
| Planned — Approximate Date | ||||
9/15/2026 | 50.51K | $3.32M | NASDAQ | Planned |
| Total | 51.15K | $3.37M | ||